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Metrics in Global Health: Situated Differences  
in the Valuation of Human Life 
Oscar Javier Maldonado & Tiago Moreira ∗ 
Abstract: »Metriken in der globalen Gesundheitsversorgung. Situative Unter-
schiede in der Bewertung von Menschenleben«. This paper explores the role of 
knowledge, standards, and metrics in global health. Our point of departure is 
the observation that the emergence of ‘global health’ as a domain of research, 
policy, and practice in the last three decades or so has coincided with an in-
creased interest in the validation and use of measures of health, such as the 
Disability Adjusted Life Year (DALY), in monitoring and assessing health equity 
across territories and populations. This ‘elective affinity’ between global health 
and health metrics has become the focus of scholarly debate in the social sci-
ences. In this paper, we seek to contextualise and critically discuss the different 
positions in this debate. We suggest that emplacing health metrics within the 
neo-liberal logic of health production –one where the ‘mechanisms of life’ are 
aligned with the maximisation of economic productivity- does not fully cap-
ture the interactive relationship between health measurement and the politics 
of health. Instead, we argue that this relationship has been characterised by 
controversy and uncertainty about how to interlock normative ideals and ap-
proaches to knowledge-making about health. 
Keywords: Metrics, DALY, Global Health, quantification, valuation. 
1.   Introduction 
This paper explores the role of knowledge, standards, and metrics in global 
health. Our point of departure is the observation that the emergence of ‘global 
health’ as a domain of research, policy, and practice in the last three decades or 
so has coincided with an increased interest in the validation and use of 
measures of health, such as the Disability Adjusted Life Year (DALY), in moni-
toring and assessing health equity across territories and populations. This ‘elec-
tive affinity’ between global health and health metrics has become the focus of 
scholarly debate in the social sciences. In this paper, we first seek to contextu-
alise and critically discuss the different positions in this debate. A critical read-
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ing of health metrics centred in the neo-liberal logics of health production does 
not fully grasp the complex relations between health measurement and the 
politics of health. Instead we show that this relationship has been characterised 
by an active debate about how to interlock normative ideals and approaches to 
knowledge-making about health.  
This analysis results from approaching the subject from the perspective of 
science and technology studies (STS). STS investigates the complex, contro-
versial processes through which knowledge and technology are brought togeth-
er within social and culturally relevant settings and relations. Contrary to what 
is usually assumed, controversies – particularly public disputes of a technical 
variety that concern most people in society – are not mere surface phenomena, 
denoting only the biases of the opposing sides. Instead, controversies should be 
seen as windows to the understanding of society-in-the-making. As Latour put 
it, controversies are “not simply a nuisance to be kept at bay, but what allows 
the social to be established” (Latour 2005, 25). This is because they substanti-
ate ways of knowing and acting on the world and concurrently mould institu-
tions, policies, and programmes. 
Controversies about standards and forms of measurement are particularly 
important from a sociological point of view. Standards – in our case, standard-
ised forms of measuring and quantifying health – are explicit, formalised rules 
or specifications informing collective engagement with objects or persons in a 
particular realm of action; in this, they are able to “regulate and calibrate social 
life by rendering the [...] world equivalent across cultures, time, and geogra-
phy” (Timmermans and Epstein 2010, 70). The normative bearing of the work 
towards calibrating and drawing equivalences is exquisitely encapsulated in 
Thevenot’s (1984) concept of ‘investment in form’, which refers to the process 
of making durable conventional arrangements – ‘a stable relation with a certain 
lifespan’ – support and enforce co-ordination between social actors. Thevenot’s 
suggestion is that these arrangements are both cognitive and normative, that is 
to say, they require both sense-making and rule-making. Subsequent work with 
Boltanski clarified this dual role of standards: 
[w]hen persons grasp events as human actions in the perspective of coordina-
tion, they relate behaviours to some relevant good, the format of the good be-
ing highly variable … When properly formatted, persons and things qualify 
for a certain mode of coordination. (Thévenot 2006, 111-2) 
Rearticulating the traditions of conflict and functionalist sociologies, Boltanski 
and Thévenot (2006) argued that, in situations of conflict and uncertainty, 
actors and groups enter into a dynamic of critique and justification with the 
goal of building conditions for the qualification of people or things in orders of 
worth. These conditions recursively act as cognitive scaffolds to understand 
situated action and act or follow rules appropriately. Importantly, they argue 
that actors’ moral justifications entail not only processes of sense-making, but 
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also require investment – or rather, durable, explicit, objectified commitment – 
as a way of ‘grasping events’. 
Although not fully adopting Boltanski and Thevenot’s emplacement of the 
dynamics of critique and justification within a set of ‘grammars of the common 
good’ (cities), we draw on their model to support our empirical description of 
controversies surrounding the ways of measuring health. From this perspective, 
standards, such as DALYs, are not mere boring, ‘technical objects’; instead, 
studying their creation provides direct insight into the building of institutions 
and the embedding of normative and epistemic arrangements. Furthermore, we 
argue that such standards are not made de novo but encounter a world that is 
already formatted. The conventional sociological framework used to under-
stand these processes differentiates between ‘universal’ standards and ‘local’ 
practices (i.e., between macro and micro scales). Boltanski and Thevenot’s 
pragmatic sociology challenges this framework by drawing analytical attention 
to critical situations and controversies as settings where the relationship be-
tween structure and agency is articulated and negotiated by social actors striv-
ing for equivalence. 
This is consequential for our approach to health metrics. Firstly, we must at-
tend to the principle of symmetry (Bloor 1991) to avoid becoming a part of, 
what Boltanski and Thevenot would call, the ‘critical sociology’ of global 
health. This is not done in an effort to rise above political disputes, but instead, 
to trace and understand how existing institutional formats became entangled 
with particular ways of knowing (e.g., Shaping and Sheffer 1985). Thus, we 
draw on scientific literature and published reports on health measurement and 
metrics to identify the network of researchers, institutions, and policies associ-
ated with different approaches to measuring population health. We ask: how 
and why did particular forms of measurement become entangled with specific 
health care policies? In the second section of this paper, we link existing cri-
tiques of the normative assumptions embedded in the DALY to an important 
and outstanding controversy in the field of public health (Sassi 2006; Voigt and 
King 2014). Dating back to the turn of the 1980s, the controversy pitted what 
came to be known as the ‘primary health care movement’ against the propo-
nents of an approach to international health care programmes that favoured 
‘rationing’. We suggest that while the former relied on an evolutionary model-
ling of the relationship between types of public health programmes and the 
health of populations, the latter flattened the historical differences between 
societies to map disease and prioritise ‘interventions’. 
As a result, we provide an analysis of health metrics that is saturated with 
diversity. Instead of seeing the consolidation of the DALY as a process unique 
to late modernity’s financialisation of health, in the third section of this paper 
we reconstitute the process through which the DALY emerged within an older, 
historically constituted ecology of health measurement. We thus suggest that 
the DALY can be emplaced within what Clarke (1991) conceptualised as a 
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‘social arena’ of health measurement – a field of action around a specific issue 
shaped by conflict, competition, cooperation, and exchange. This provides 
insight into the relational underpinnings of the DALY’s genesis and develop-
ment. By opening the analysis of health metrics in global health to this wider 
field of action, the DALY can be understood as the contingent outcome of an 
on-going process of negotiation. By exploring how ‘it could have been other-
wise’ (Bijker and Law 1992), our paper opens the imagination to path and 
possibilities of alternative ‘investment in form’ in health.  
2.  Measuring Global Health 
Historical analyses usually agree that the transition from international to global 
health is evidenced in the consolidation of a multi-actor approach to financing, 
organising and delivering health technologies and interventions in the 1990s, 
often underpinned by a collective belief that health can stimulate economic 
development (Packard 2016). For many, this transition was marked in two key 
publications: the 1993 World Bank World Development Report: Investing in 
Health and the 1996 Global Burden of Disease (GBD) Study report (Murray 
and Lopez 1996). The report from the World Bank is seen to have set the re-
form agenda for healthcare system in the developing world, arguing for a 
‘modernisation’ strategy underpinned by the overall goal of efficiency delivery 
through “greater diversity and competition” (World Bank 1993, iii). Seeing 
efficiency as driven by the optimal distribution of resources obtained from 
competition between alternatives, the World Bank further advocated that this 
aim could be obtained by maximising the ratio between input resources – at a 
specific cost – and a specific health outcome (World Bank 1993, 25). The GBD 
Study, which the World Bank funded along with the World Health Organisa-
tion (WHO), proposed that it was necessary to develop a ‘single measure’ to 
attain this efficiency goal, or rather, an “internationally standardized form” that 
would support “policy-makers [in comparing] the relative cost-effectiveness of 
different interventions” (Murray and Lopez 1996, 6-7) as well as comparing 
health care systems across space and time. In focusing on developing a metric, 
they were motivated by the view that countries’ main burden of disease could 
no longer be straightforwardly divided along a communicable/non-
communicable disease line and that the “so called ‘epidemiological transition’ 
[was] already much further advanced [in the South] than many public health 
specialists appreciate[d]” (Murray and Lopez 1996, 1). 
In 1971, the epidemiologist Abdel Omran proposed that the processes of 
demographic transition of populations with high fertility and mortality towards 
low levels of fertility and mortality had been paralleled by a change in the 
dominant cause of death in the population. It was first characterised by ‘famine 
and pestilence’, then by ‘pandemics’, and finally by ‘degenerative diseases’ 
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(Omran 1971). Although this model was mainly designed to argue for the im-
portance of public health infrastructure in decreasing mortality, as evidenced 
by the demographic transition theory (see below), the paper quickly became a 
reference point for emerging controversies and debates about both the nature of 
the relationship between mortality, morbidity, and the quality of life in high-
income countries (Weisz and Olszynko-Gryn 2009; Moreira 2016). 
Such emphasis on the power of metrics in propelling the transformation of 
health care across territories and populations has recently attracted the interests 
of scholars from anthropology, sociology, and science and technology studies 
(STS). Focusing on the role of such metrics in the shaping of contemporary 
governance of global health, these studies enable, in turn, the identification of 
the normative assumptions, local implications, and institutional consequences 
of standardised measures of global health. 
Drawing on a Foucauldian framework, Wahlberg and Rose (2015) explore 
the GBD Studies as a new technology of the governmentalization of life 
through the quantification of disability. Noting a shift in the forms of 
knowledge produced about populations, from mapping disease patterns to 
calculating the state of world health, they argue that this denotes a new epide-
miological style of thought in which “the problem of morbid death gives way 
to that of morbid living, made calculable through a metrics of ‘severity’, ‘disa-
bility’ and ‘impairment’” (Wahlberg and Rose 2015, 60). In this process, the 
social and personal consequences of living with disease become an object of 
political concern that is made both knowable and calculable; thusly, it becomes 
a target of intervention. This new style of thought, they argue, drawing on GBD 
documentation, can be traced back to the development of the concept of ‘epi-
demiological transition’. 
In 1971, Daniel Sullivan published what is considered a seminal contribu-
tion to the measurement of health: an index of ‘health expectancy’ that calcu-
lated ‘Disability-free Life Expectancy’ (Sullivan 1971). Designed as a rational 
and empirical formula to assist decision-making when “public health pro-
grammes compete with each other and with other government activities for 
budget allocations” (Sullivan 1966, 1), the Sullivan method is a key exemplar 
in a more general shift towards the measurement of quality of life from the 
1970s onwards (Bowling 2005). Addressing this shift, Armstrong and Caldwell 
(2004) argue that the rise of this ‘quality of life’ repertoire can be seen as coun-
terpoint to “the dream of a technological future” in health care. By measuring 
function or subjective well-being, such measures bring to bear the often modest 
benefits of biomedical technologies in the lives of patients. This being said, it is 
important to recognise that this questioning was closely linked to both an ob-
served stabilisation of mortality levels in the populations of high income coun-
tries in the 1960 and 1970s (Manton 1992) and the shared belief that only tech-
nological advances in chronic disease management – or ‘degenerative diseases’ 
– would enhance survival rates (Moryama 1964). 
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For Wahlberg and Rose, these new health metrics are equally encased by 
what they label a ‘new epidemiological gaze’ where the focus moves from 
“biological processes and events of life (disease and death) to social processes 
and events of living (disability and health)” (Wahlberg and Rose 2015, 86) in 
the management of populations. They thus see continuity between the health 
measurement movement of the 1970s and the later work developed by the 
World Bank and the GBD Studies. While this might be justified by the fact that 
the key metric proposed by the GBD studies – the DALY – can be seen as an 
adaptation of the Sullivan method, there are significant technical differences 
between the metrics used. Usually, Sullivan health expectancies are measured 
by computing different states of health to obtain an aggregate of ‘full health’. 
By contrast, the DALY focuses on measuring the effects of a disease in reduc-
ing “human function”, one DALY being equivalent to a ‘one lost year of full 
health’. Epistemically, the DALY can be grouped with measures of mortality 
and morbidity that focus on Years of Life Lost (YLL). 
Table 1: Burden of Disease Metrics 
Metrics Formula/Definition 
YLL YLL = N x L where: 
N = number of deaths 
L = standard life expectancy at age of death in years 
YLD YLD = I x DW x L where: 
I = number of incident cases 
DW = disability weight 
L = average duration of the case until remission or death (years) 
DALY DALY = YLL + YLD. 
The disability-adjusted life year (DALY) is a measure of overall 
disease burden, expressed as the number of years lost due to ill-
health, disability, or early death. 
QALY QALY=Years of Life x Utility Value 
The years of life remaining for a patient following a particular 
treatment or intervention and weighting each year with a 
quality of life score. 
 
Introduced by Mary Dempsey in 1947 with the aim of comparing mortality due 
to tuberculosis with heart diseases and cancer (Romeder and McWhinnie 
1977), YLL specifically focused on causes of mortality for setting priorities in 
health care – those causing more mortality being higher in the ranking of con-
cern and investment. Regularly published by national statistical agencies by the 
1970s, YLLs were a relatively stable set of procedures in epidemiology, not 
only because it used the central epistemic referent in epidemiology – death – 
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but also because it could rely on readily available data on causes of death. It is 
from this perspective that it can be said that the DALY “extends the notion of 
mortality gaps to account for time lived in health states worse than ideal 
health” (Murray, Salomon, and Mathers 2000, 983).  
Despite these conceptual differences, Wahlberg and Rose propose that there 
are key commonalities across metrics in that they enable forms of power that 
are conceived and implemented as “strategies for prioritization and evaluation” 
(Wahlberg and Rose 2015, 86). This is significant because it links the quantifi-
cation of health to a mode of public health intervention that enacts healthcare 
as specific technological packages and programmes, whether to maximise 
health expectancy or to minimise health gaps. 
From the same governmentality approach, Kenny (2015) analyses the design 
of the DALY and its role in the governance of global health. Focusing her 
analysis on the World Bank’s formulation of the DALY, Kenny argues health 
metrics accomplish an ‘economization of life’ by disaggregating lifetimes into 
component units of time. Through this procedure, it is possible to represent life 
as a revenue stream to be maximized through practices of self-investment in 
one’s own health. In this, health is configured in terms of human capital ex-
pressed in the use of age weighting, discounting rates, disability severity 
weighting and standard life expectancy, the key procedures used in the DALY 
approach to derive measures of ‘lost heath’ (Kenny 2015, 12). 
This linkage to the concept of ‘human capital’ provides Kenny with a bridge 
between health metrics and the wider transformations of what (2009) labelled 
as neo-liberal forms of power-knowledge and, in particular, by how the theory 
of human capital enacts labour as a combination of ability and investment 
(education, etc.) from which an income can be obtained. Human capital, as 
understood in economics, is the stock of skills that people possess. This stock 
increases the value of people as a labour force (Becker 1962, 9). “The flow of 
these skills is forthcoming when the return to investment exceeds the cost (both 
direct and indirect)” (Goldin 2014, 53). Human capital encompasses the notion 
that investments in people, such as education, training, and health, increase an 
individual’s productivity and, therefore, value. From this perspective, Kenny 
proposes that health metrics can be understood as ‘technologies of govern-
ance’, by reducing uncertainty on the types of investment, health technologies, 
or services that produce health and maximise the value of individual labour 
(Kenny 2015, 12).  
The consequences of framing health in such a narrow way are brought to 
bear in Adams’ (2016) ethnography of the impact of audit practices and quanti-
fication in global health. Emphasising the role of international organisations, 
NGOs, and governments in this process, she argues that they have led to a dual 
economization of health and fiscalization of life. Similarly to Kenny, Adams 
sees the economization of health as resulting from the adoption of ways of 
organizing and thinking about healthcare from economics, particularly those 
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based on understanding healthcare as a market. The fiscalisation of life is relat-
ed with the increasing participation of actors from the financial sector in global 
health. In these processes, health metrics are key instruments in the economiza-
tion of health. Furthermore, different health metrics also enable the mainte-
nance of distinctions between economic regions of the globe, the emphasis on 
‘quality of life’ (QALY) being distinguished from that of ‘disability’. Such 
distinctions make sense, Adams argues, because:  
in the Global North what mattered was counting the cost of keeping people 
alive, whereas in the Global South what mattered was plausible justification 
for continued expenditures in relation to death and disease burden. (Adams 
2016, 27) 
Adams major concern is the side effects of these calculations. By emplacing 
healthcare in a market frame, countries, communities, and healthcare providers 
have to adjust to the demands of data production. Thus, the production of data 
regarding the impact of investment in health becomes the major goal of strate-
gies and funded projects rather than the actual delivery of healthcare. This 
exerts violence, particularly through the necessary arithmetic gymnastic to 
make countries comparable, and the pretention of value neutrality in resource 
allocation that these metrics make possible (Adams 2016, 30). Finally, for 
Adams, the most serious consequence of the economization of health is to think 
of life as money, substituting politics for a market principle. This renders mar-
ginal and invisible other forms of evidence and other experiences in global 
health that – despite working in practice – cannot be translated into the lan-
guage of the market (Maldonado 2018). This ‘silencing’ of the local ways of 
enacting and valuing health practices endangers the sustainability of global 
health programmes and undermines health equity as a principle. 
Drawing on Foucault’s writings on governmentality, Wahlberg and Rose 
(2015) and Kenny and Adams (2015) provide an important set of insights into 
global health as an apparatus of power-knowledge, highlighting the historically 
constituted, political and economic contexts in which it emerged. Their analysis 
is particularly relevant to understand how specific modes of knowledge making 
and evaluation of evidence became uniquely suited to support forms of govern-
ance that seek to maximise efficiency in the delivery of discrete interventions 
and technologies. This brings to bear the contingent nature of current global 
health processes and institutions while providing important clues on their gene-
alogy. However, a disadvantage of this analytical approach is that it departs 
from the central role that metrics, such as the DALY, play in contemporary 
global health and tends to understate the controversies and indecisions that led 
to the present situation. To recover the paths not taken and to fully account for 
ways of enacting and valuing health that have been silenced, it is necessary to 
focus on the institutional transformations of international health governing 
during the second half of the twentieth century and to ask the question: What 
other forms of global health policy could have been possible? 
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3. Recovering Diversity in Global Health: Social Change 
vs. Efficiency 
In this section, we aim to recover some of the epistemic and political diversity 
that preceded the stabilisation of the global health apparatus as we know it 
today. To do this, we shift our focus from the establishment of this assemblage 
in the 1990s to explore a wider, longer process. As suggested by Cueto (2004), 
it is possible to link the focus on metrics in global health to a controversy about 
the role of primary health care in international health policy in the late 1970s 
(See also Brown et al. 2006; Rodin 2013). 
As we argued above, in the 1970s, experts such as Omran aligned with poli-
cy makers and the WHO to propose a focus of international health on primary 
health care (Cueto 2004). Through the motto ‘Health for All’, the primary 
healthcare movement agenda expressed a social understanding of health and a 
belief that policy should be focused on the improvement of living and material 
conditions of the poor. It proposed deploying community-embedded physicians 
as agents of change. Support for this position came both from the acceptance of 
social epidemiological models of public health, such as McKeown’s model 
(1976), and from:  
a new political context characterized by the emergence of decolonized African 
nations and the spread of national, anti-imperialist, and leftist movements in 
many less-developed nations. (Cueto 2004, 10) 
This political orientation was expressed in the Alma-Ata declaration of 1978 
which, as the principles of the primary health care movement, identified the use 
of appropriate technologies, the opposition to medical elitism, and a concept of 
health as a tool for socioeconomic development (Cueto 2004, 12). A year later, 
the 32nd World Health Assembly endorsed the conference’s declaration. 
In the context of the Cold War, however, the Alma-Ata declaration was not 
well received by the main international donors, particularly by the United 
States. The declaration was accused of being abstract and too holistic to define 
specific, grounded policies (Schwartländer, 1997). Key amongst the critics was 
the Rockefeller Foundation’s concern with the lack of strategies to define prior-
ities in international health. This led to it sponsoring a small conference in 1979 
entitled Health and Population in Development at its Bellagio Conference 
Centre in Italy. The conference gathered representatives from the Work Bank, 
the Canadian International Development and Research Centre, the Ford Foun-
dation, and the US Agency for International Development (USAID). As its 
main outcome, the conference led to the production of a report written by Julia 
Walsh and Kenneth S. Warren (1979) where an alternative set of principles to 
the Alma-Ata conference and the World Health Assembly were outlined. 
Entitled Selective Primary Health Care, an Interim Strategy for Disease 
Control in Developing Countries, the Bellagio Centre conference report is key 
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to understanding the stabilisation of the global health assemblage as we know it 
today (Walsh and Warren 1979). Casting the objectives of the Alma-Ata con-
ference as “laudable but unattainable in terms of its prohibitive costs and the 
numbers of trained personnel required” (Walsh and Warren 1979, 145), the 
authors proposed that the concept of selective primary health care should be 
underpinned by the need to set priorities in what health programmes and inter-
ventions to finance. This entailed two sets of data generation: identification of 
target diseases based on assessments of prevalence, morbidity, and risk of 
mortality; and evaluation of the medical interventions used to manage those 
illnesses, which was to be supported by measures of effectiveness and cost. 
Primary healthcare, the report argued, should focus on cost-effective interven-
tions that reduce most of the burden of a particular disease – measured here as 
numbers of deaths – to the lowest cost. This approach was thus to be infrastruc-
turally supported by a combination of measures that detailed the differential 
contribution of specific diseases to the overall mortality, with assessment of 
effectiveness produced through randomised controlled trials of specific inter-
ventions. 
Their proposals came to bear one year later in the Kaiser Foundation Inter-
national-sponsored Ghana Health Assessment Project (GHAPT 1981). Seen as 
a key technical antecedent to the formulation of the DALY and the GBD study 
of 1993 (Murray, Salomon, and Mathers 2002), the project was explicitly moti-
vated by the apparent lack of progress in levels of population health despite 
increases in health care facilities and personnel in Ghana. To examine this, the 
investigators designed a method to estimate the health impacts of different 
diseases, thus enabling the examination “of the magnitude of the change [health 
interventions] might be expected to produce in health status” (GHAPT 1981, 
73). Recognising the technical difficulties of measuring the impact of illness in 
economic activity, the project team opted for a measure of ‘healthy days of life 
lost’ as a proxy assessment of the impact of illness on productivity. This form 
of measurement, in turn, was deemed able to formulate priorities by quantify-
ing the “healthy life saved” by, for example, a measles immunisation program 
vis-à-vis an outpatient clinic for the same condition. These arguments, it was 
suggested, should be more “persuasive […] than the mere assertion that pre-
vention is better than cure” (GHAPT 1981, 77). 
This contrast between ‘mere assertion’ and ‘quantification of healthy life’ 
makes reference to the controversial nature of the Ghana project team and the 
Bellagio Centre conference’s proposals. Although not explicitly challenging 
the alternative position, it aimed to grade the epistemic quality of different 
approaches to prioritisation. In doing so, it provides, albeit from a biased 
standpoint, the link between styles of reasoning and knowledge making about 
population health and the politics of health care that underpins this controversy. 
The conflict was thus about the politics of knowledge in international health. 
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On the one side, there was the loose alignment of institutions, agencies, and 
actors that formalised the Alma-Ata declaration – a coalition that, until the 
mid-1970s, included the World Bank itself – in its support for prioritising of 
sanitary conditions and housing “as causes of poor health” (World Bank, 
1975). They proposed that priorities should result from an understanding of 
basic rights and key principles. Indeed, the Alma-Ata declaration recommend-
ed that, in order to achieve a socially and economic productive life, it was a 
necessary condition that citizens were given access to basic sanitation and 
water supply, immunization against major infectious diseases, maternal and 
child health, health education, etc. (WHO 1978, 2). Contrary to the Ghana 
team’s claim, this was not a ‘mere assertion’: it was based on established ways 
of analysing mortality and morbidity data, perhaps best epitomised in Omran’s 
model of epidemiological transition. Omran’s model drew on the developmen-
tal narrative of demographic transition theory, which had underpinned many of 
the fertility programmes implemented in the ‘third world’ by the UN, to pro-
pose that “mortality is a fundamental factor in population dynamics” (Omran 
1971, 511). The model suggested that, while transition to the ‘age of receding 
pandemics’ had been sustained by the introduction of basic sanitation and other 
infrastructural changes, the shift to the low level equilibrium of the ‘age of 
degenerative diseases’ could only be achieved by widening access to basic 
health care provision (e.g., maternal health, etc.) (Weisz and Olszynko-Gryn 
2009). I would suggest a sentence restructure.  How does this sound? ‘For 
those supporting the Alma-Ata declaration, this developmental way of reason-
ing about populations, if not directly the theory itself, provided a sound, robust 
basis for the elaboration of priorities and public health programmes that fitted 
the needs of specific populations. 
On the other side were those that, as described above, argued that the scarci-
ty of resources available dictated the need for a different way of setting priori-
ties in international health. By the late 1970s, however, these were in a relative-
ly marginal position (see WHO 1978). To overcome this, proponents of the 
selective approach had to challenge two aspects of the Alma-Ata line of reason-
ing. Where the latter saw health as a driver of economic wealth creation, the 
position of the Rockefeller Foundation and the World Bank was that available 
economic wealth constituted an antecedent restriction on the investment in 
health (McNamara 1978). By highlighting the shortage of resources limiting 
the formulation of policies, they were returning to Malthusian-type arguments 
about the regulatory role of scarcity in the dynamics of populations, which 
demographic transition models had originally attempted to displace (Ramsden 
2002). Now encased in the language of mainstream economics, scarcity en-
tailed the formulation of choices with differing opportunity costs. But how 
were those choices to be articulated? Answering this required a critique of the 
epistemic basis used by those supporting the Alma-Ata declaration. As Walsh 
and Warren put in their report on the Bellagio Centre conference: 
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The state of ill health found in many less developed countries should not be 
approached as a single problem. Traditional indicators such as child mortality 
or life expectancy are insufficient for grasping the issues involved. Health is 
complex multifaceted problem, an amalgam of many diseases with multiple 
causes. Indicators are actually distilled composites of hundreds of different 
health problems and disorders. […] Diseases endemic to the less developed 
countries are protean in their etiologies, mechanisms of transmission, impacts 
on humans and susceptibility to attack. It is unlikely that any single mode of 
would be suitable for all. Each disease must be considered individually, with 
its unique mix of epidemiological, ecological and social factors. (Walsh and 
Warren 1979, 145-6)   
Instead of patterns of mortality related to general types of disease (e.g., infec-
tious diseases), Walsh and Warren proposed that morbidity could be disaggre-
gated into different ‘etiologies’. This made indicators such as child mortality or 
life expectancy inadequate to capture not only the mechanism of disease causa-
tion but also the impact of ill health on persons. They were thus ill equipped to 
serve policy formulation. Such a disparaging assessment of the value of life 
expectancy to understand population health is of key significance. Although at 
least since the 1960s, as discussed above, researchers had been trying to devel-
op metrics that could capture the ‘quality’ of life lived, most notably by Sulli-
van (1970), these, as the GHAPT put it, “did not relate […] to specific diseases 
and thus [were] not likely to be of direct value in determining the allocation of 
health resources” (GHAPT 1981, 77). The indicator that most suited such pur-
pose, they argued, was instead the concepts of ‘healthy life lost’ to illness, 
which had originally been developed by Dempsey in 1947 to question the value 
of mortality rates in creating the emergent view that the significance of tuber-
culosis was decreasing in the US (Romeder and McWhinnie 1977).  
Further, it was an accepted view amongst those attempting to develop 
measures of population health that ‘quality of life’ calculations were best suited 
for societies where the prevalence of chronic disease justified a focus on the 
impact of illness on social functioning (e.g., Sullivan 1966, 1). These were 
assumed to map onto societies in the ‘developed world’, but, during the first 
half of the 1980s, the WHO Global Epidemiological Surveillance and Health 
Situation Assessment Unit led a series of studies that questioned the neat map-
ping between development regions of the world and the prevalence of types of 
disease. For example, using WHO mortality data, it was found that “50% of all 
deaths in the world due to [cardiovascular illness or cancer] occur in the devel-
oping world” (Hakulinen, Hansluwka, Lopez, and Nakada 1986, 347). Using 
mortality data was important because it directly challenged the epidemiological 
transition model with its own preferred statistic. This challenge, however, did 
not lead to a rejection of the epidemiological transition theory. What appears to 
have happened is that, for those supporting a selective approach to international 
health care programmes, the model came to refer to overlapping patterns of 
mortality observed in developing countries, losing its explanatory power along 
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the way (e.g., WHO 1991, 75). The shift was such that by 1994, the GBD lead 
researchers would propose that, in developing countries the “so-called ‘epide-
miological transition’ is already much further advanced than many public 
health specialists appreciate” (Murray and Lopez 1994, 2: our emphasis). 
To a very significant degree, this controversy is still unresolved (Shreker 
2015). On the one side, there are those, endorsed by the WHO and supported 
by the Melinda and Bill Gates Foundation, who argue for the need to validate 
new methodologies and implements to ascertain the value of health interven-
tions across populations. This can be seen as epitomised in the establishment of 
the Institute of Health Metrics and Valuation and the GBD 2010 study, which 
aimed, as referred above, to measure the quantity of health in terms of the 
‘limitations’ illnesses imposes “on what [persons] can do in life” (Salomon et 
al. 2013). They favour methodologies that aim to identify ‘gains’ in health 
obtained from the application of discrete interventions and simulate the ideal of 
economic choice of investment in the face of scarce resources. On the other 
side, there are those who argue that existing statistical techniques enable the 
identification of constant conjunctions between socio-economic conditions and 
public health infrastructure, and health outcomes across populations (Scribner 
et al. 2017). They thus place less value on developing a standardised measure 
of health gain and more on making visible and quantifying the inequalities and 
inequities in global health. For them, health research should not be concerned 
with the question of whether public health interventions work but, instead, with 
understanding the process of making them work in specific contexts; it is not a 
question of if, but how. 
4.  Context Means Comparison 
In the first section of the paper, we have suggested that contemporary social 
science research has identified a key role for health metrics in the governance 
of global health processes. In this, there is some agreement that health metrics 
support understanding and managing health care through an economic framing, 
both in terms of how health is seen to lead to economic development and how 
decision making is deployed as a discrete choice between alternative ‘goods’. 
We have argued, however, that this analysis partially glosses over the uncertain 
and controversial nature of using DALYs to allocate health care resources 
across populations. Such a proposal is better understood against an agonistic 
background, where divergent ways of linking knowledge making on population 
health to health care policy and institutions have maintained a dynamic of 
critique and justification for at least three decades. 
The key consequence of this analysis is the realisation that health metrics 
should not be investigated in isolation. As was suggested on both sections, 
DALYs belong to a wider set of health measurement techniques and proce-
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dures; while the DALY has been the main form used to measure health in the 
Global South, its generation and transformation is integrated in a wider history 
of health measurement and valuation, as was indicated above. Health meas-
urement assembles what Clarke (1991) would label a ‘social arena’. The im-
portance of this wider field of action was, in fact, acknowledged by the devel-
opers of the DALY themselves in the GBD publication that first described the 
metric: 
In order to capture the impact of both premature death and disability in a sin-
gle measure, a common currency is required. Since the late 1940s, researchers 
have generally agreed that time is an appropriate currency: time (in years) lost 
through premature death, and time (in years) lived with a disability. A range 
of such time-based measures has been developed in different countries, many 
of them variants of the so -called Quality Adjusted Life Year or QALY. For 
the GBD, an internationally standardized form of the QALY has been devel-
oped, called the Disability Adjusted Life Year (DALY). (Murray and Lopez 
1996, 6-7) 
Opposing the use of a common currency to the ‘partial and fragmented’ health 
statistics of specific causes of death, Murray and Lopez emplace their new 
metric within a longstanding field of research where there is consensus that 
time (years) should be deployed as basic unit of measurement. This consensus, 
they suggest, has enabled the generation of a variety of measures which can be 
grouped around the idea of Quality Adjusted Life Year, of which the DALY is a 
variant. Thus, it is proposed that this represents an ‘international standardised 
form of the QALY’. 
Given what was discussed in relation to the DALY in the previous section, 
Murray and Lopez’s assertions might appear unusual. This is because it is now 
accepted that, if anything, the DALY represents the negative of QALY, meas-
uring disability or ‘healthy life lost’ instead of quality of life, or as Murray, 
Salomon, and Mather (2000) would put it years later, measuring ‘health gaps’ 
rather than ‘health expectancy’. However, in the moment that Murray and 
Lopez were writing the QALY, it represented the most widely known metric 
used in health. As such, it constituted a point of reference, or rather, a signifier 
for an ‘arena’ into which the DALY could be placed. This was important for 
GBD lead researchers because it enhanced the DALY’s differentiation from the 
‘partial and fragmented’ health statistics used by public health researchers and 
advocates (i.e., those who relied on ‘epidemiologic transition’ arguments to 
justify policies). Like the QALY, the GBD researchers argued that the DALY 
aimed “to disentangle epidemiology from advocacy in order to produce objec-
tive, independent […] assessments of health” (Murray and Lopez 1996, 6). 
Linking the DALY to the QALY thus enabled the establishment of a boundary 
between the previous work done by epidemiologists comparing the health of 
populations, such as Omran, and the work of the WHO GBD studies team. 
Crucially, like the QALY, it did such assessments in order to “allow policy-
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makers to compare the relative cost-effectiveness of different interventions” 
(Murray and Lopez 1996, 6). 
However, GBD researchers were attempting to differentiate between QALY 
valuations, which depended not only on different techniques of quantification 
but also on how different societies valued health, and a form of valuation that 
enabled comparisons between territories and populations. This aim hinges on 
the ability to craft what Mol (2002) labelled as a ‘comparative platform’, or 
rather, an operation supported by techniques that place differences and similari-
ties between cases side by side (Moreira 2007; Stengers 2011; Deville, Gug-
genheim, and Hrdličková 2016). In so doing, it creates that which is compared, 
that is to say, comparison elicits value that is commensurate. However, rather 
than producing commensuration by negotiating and compromise, as did QALY 
proposers, the DALY was firmly attached to a set of ‘value judgements’, which 
Murray and colleagues deemed to be ‘equalitarian’. Such value judgements 
underpin the technical basis of valuation in the DALY approach: its focus on 
time lost, the emphasis on healthy live lost in the proximate future, the use of 
standardised disability weights, and the differential valuation of time lived at 
different ages. The latter two are particularly illustrative of the process of 
standardisation underpinning the DALY.  
With regards to age-weighting, instead of linking differential valuation of 
disability by age to ‘productivity weights’, as would be predicted by the theory 
of human capital, DALY champions viewed “unequal age-weights as an at-
tempt to capture different social roles at different ages” (Murray 1994, 435). 
Moving away from a strictly economic valuation of social functioning, sug-
gested for example by the World Bank (1993) (see above), they emplaced 
value judgement on the ‘original position’, or rather, the ‘thick veil of igno-
rance’, which was a thought experiment proposed by Rawls (1971) and much 
used in the health policy thinking (e.g., Menzel 1999). Interestingly, in an 
effort to operationalise this experiment without deriving weights by application 
of general principles to the relationship between age and role, they conducted a 
Delphi conference with ‘public health experts’ so as to obtain a function of 
weighting by age. 
In relation to disability weighting, although using the similar consensus gen-
erating techniques, the procedure hinged on a specific normative differentiation 
that would prove problematic. The WHO International classification of im-
pairments, disabilities, and handicaps (1980) differentiated between ‘disability’ 
– a functional limitation resulting from an organic impairment – and ‘handicap’ 
– a socio-economic disadvantage or impact resulting from functional limitation. 
Recognising the attraction linked to measuring handicap, DALY proponents 
were concerned that it might lead to reinforcing inequalities as the ‘same’ func-
tional limitation would be valued differently depending on the context where 
people lived (Murray 1994, 437-8). This decision had the key advantage of 
enabling weights to be generated without knowledge of the particular circum-
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stances experienced by individuals. This meant that disability was defined by 
‘universal’ human abilities such as seeing, speaking, grasping, and activities 
such as dressing or washing. 
Both age-weighting and disability weighting proved to be, for different rea-
sons, especially problematic features of the DALY (Voigt and King 2012). Age 
weighting was attacked for relying on the assumption that the disabling effects 
of disease become less significant with age. It was not only that procedure 
made widespread suppositions about the value of older people in society across 
cultures, but also that it was going against the emerging scientific and political 
questioning of chronological age as a valid index of an individual’s  function or 
health (Moreira 2016). As in the domain of disability politics, activists argued 
that such beliefs effectively prevented older people from participating in social 
and economic life. 
Indeed, by the turn of century, the WHO itself had articulated a policy 
framework – ‘active ageing’ – that explicitly aimed to optimise economic, 
social, and cultural participation throughout the life course by removing barri-
ers to participation, which included the incorporation of older people in re-
search (Lassen and Moreira 2014). Response to this shifting context and to 
challenges from bioethicists (see Murray, Salomon, Mathers, and Lopez 2002, 
Part 13) entailed making age weights progressively uniform in the GBD 2010 
(Voigt and King 2014, 226). 
However, criticisms related to disability weights proved more challenging as 
it questioned the very possibility of comparing levels of health across popula-
tions and time points. While the solution to the age-weighting problem rein-
forced the internal consistency of the standard, disability politics threatened to 
undermine the key comparative aims of the DALY (Murray and Lopez 1994). 
To address this problem, new weights were defined through surveys in which 
lay descriptions of different health states were used to elicit valuations (Ustun 
et al. 2001). These were not seen as reflecting preferences, as in the QALY 
approach, but instead as appealing to an ‘intuitive, common sense’ notion of 
health (Murray, Salomon, Mathers and Lopez 2002, 736-7) which allowed 
cardinal grading of health states. It was then possible to map differentiated 
weights onto the territorially bound prevalence of disease and disability data. 
The aim, however, remained to isolated loss in health from disadvantages in 
welfare and from the impact of the social environment. In this, the goal was to 
measure ‘health’ in a narrow sense, independent of welfare and socio-cultural 
differences. 
Such belief in the ability to isolate health from welfare and social context is 
precisely the major criticism Voigt and King make to the GBD 2010. They 
argue that this belief is not only ill founded, as health is interdependent on 
social, economic and cultural conditions (Blaxter 2004), but also that it entails 
a narrowing of the criteria for political making decision making [do you mean 
‘political decision making’?]. They suggest that while using metrics such as the 
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DALY might be key to monitoring health equity across the globe, this should 
be distinguished from “using them to determine priorities and allocate re-
sources among different diseases in different countries” (Voigt and King 2014, 
227). However, as was argued above, the comparative epidemiological aim 
cannot be easily separated from the politics of decision making. For GBD 
researchers, the mapping of disease burden and valuation of ‘healthy life lost’ 
is aimed at shaping, or disciplining, how decisions are made. This, in effect, 
requires foregoing complexity for commensurability or comparability. As the 
GBD lead researchers put it: 
Comparability is fundamental to the use of survey results for development of 
evidence for health policy but has been under-emphasised in instrument de-
velopment [...] The basis of science is comparable measurement: comparison 
creates possibilities of investigating broad determinants at national and cross-
national level. […] Health measurements, particularly for policy makers, gen-
erally only have meaning in context, and context means comparison. (Murray, 
Salomon, Mathers and Lopez 2002, 746-7) 
Context means comparison. By presenting comparability as the condition for 
good, rational and effective decision-making, the GBP researchers situate local 
and national policy in a scenario in which the international context guarantees 
objectivity. Context is, in this case, the type of information available for the 
decision maker. As with the QALY, health measurement is defined in relation 
to an imagined type of decision making for which normative assumptions are 
made. In practice, however, such assumptions operate through infrastructures 
in which measurement and evaluation are the gateway for funding and pro-
grammes justification. 
5.  Conclusion 
Health metrics can be conceptualised as a social arena (Clarke 1991). They 
have been shaped by reference to each other and by common conflicts, connec-
tions, and exchanges. These metrics have shaped Global health as a domain of 
research, policy, and practice. A closer view to the development of metrics, 
such as the DALY, has shown the interactive relation between health meas-
urement and politics of health. This relation has been characterised by uncer-
tainty and debates between epidemiologists and other global health experts 
about the consequences of measuring in health decision-making. 
This paper has presented some elements to help with the understanding of 
the entanglement between metrics and specific health policies. Measurement 
and quantification in health have been aspects of a contested field in which the 
conceptions of health and social policies have been debated, negotiated, and 
legitimated. Our starting point was the social science scholarship about global 
health metrics. These works have shown how the market, as a normative mod-
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el, has shaped health policy and the key role of metrics in this process. Howev-
er, as we have presented, this account is partial and does not take into consider-
ation the contested development of these metrics nor the debate in public and 
global health about their normative assumptions. We have presented two facets 
of this process: the roots of the DALY in the controversy about primary health 
care and the epistemological connections between health and measurement. 
The metrics are health currencies based on time. 
The controversy surrounding primary health care has shown the political in-
terest in establishing a monopoly on the measurement and quantification within 
healthcare. Despite the Alma-Ata formation being based on the epidemiologi-
cal transition model, its critics claimed that the lack of the right measuring 
infrastructure made the declaration abstract and idealistic. The DALY and the 
Global Burden of Disease are the development of a critique that introduced 
scarcity in health measuring and decision making. Scarcity will reach a regula-
tory role, encased in the language of mainstream economics. The discussion 
about costs of opportunity and cost-effectiveness that scarcity entails are put in 
the centre of health measurement. 
This paper has examined the origins of the DALY as an international stand-
ardised version of QALY and the epistemology that these metrics share. The 
development of the DALY and the Global Burden of Disease shows the use of 
standardisation and quantification as a response to what is, from a technocratic 
perspective, perceived as conventional politics. However, as we have present-
ed, such standardisation is generative and has made new debates about the 
normative assumption of health decision-making possible. In attempting to 
address critiques, the DALY has revealed its conventional basis and its limita-
tions in capturing the ‘value of health’ for specific populations. 
The most remarkable feature of the DALY is its comparability across types 
of illness, but most importantly across nations. The importance of comparison 
is a consequence of the interest of GBD researchers in establishing a concept of 
health independent of references to socio-cultural specificities and material 
context. DALY and GBD infrastructures are shaped by a commitment to cap-
turing health as a ‘pure’ quality. Through comparability, the DALY provides 
its own context and becomes the basis of objective health decision-making. 
We are witnessing the development of an institutional complex of metrics, 
policies, and funding in Global health based on the idea that measuring ‘health’ 
in a narrow sense, independently of considerations about welfare and socio-
cultural differences, constitutes the best way of tracking the effectiveness of 
interventions and policies. These metrics provide a context for decision making 
that is significantly affecting how policies, interventions, and resources are 
justified and contested. Our paper has hopefully contributed to opening the 
framing of these decisions. By exploring the paths not taken, our paper offers 
new possibilities for an alternative standard and ‘investment in form’ in global 
health. 
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